Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease small cell carcinoma
Comorbidity C0684249|lung carcinoma
Sentences 9
PubMedID- 22685658 As lcnec has not been found to be highly amenable to chemotherapy, as compared to small-cell lung carcinoma (sclc), a diagnostic test is needed in order to separate the lcnec patients from lc and sclc.
PubMedID- 24634783 Because of the morphological and immunohistochemical similarity of mcc to small cell lung carcinoma (sclc), chemotherapy has been performed with protocols based largely on agents active in sclc.
PubMedID- 20939874 Small cell lung carcinoma (sclc) is found in over half of patients [10].
PubMedID- 21464878 Most of the scc literature to date focuses on small cell lung carcinoma (sclc), which comprises 25% of all lung cancers.2 while 96% of small cell carcinomas originate in the lung,2 small cell carcinomas can arise from multiple sites in the body, including the gastrointestinal system, larynx, pharynx, paranasal sinuses, uterus, cervix, ovaries, bladder, and prostate.
PubMedID- 21147621 Small cell lung carcinoma (sclc) formed 25.0% of all cases in the chromium exposed workers and 16.3% in the non-exposed individuals.
PubMedID- 24287699 Squamous cell lung carcinoma, a subtype of non-small cell lung cancer (85% of all lung cancers), which accounts for 25–30% of all non-small cell lung cancers, had the third highest fold-change24 (figure 7f).
PubMedID- 21062477 Nci-h82 and nci-h146 small-cell lung carcinoma (sclc) cell lines were obtained from the american type culture collection (atcc, manassas, va) and were maintained in rpmi medium supplemented with l-glutamine and antibiotics as described by atcc.
PubMedID- 21811665 Small cell lung carcinoma (sclc) and non-small cell lung carcinoma (nsclc) are two main distinct types of this neoplasia that have considerable differences in pathogenetic mechanisms, cellular origin, molecular changes and histopathological and clinical features [1].
PubMedID- 25902707 Small cell lung carcinoma (sclc) has primarily been treated with platinum based chemotherapies in conjunction with thoracic radiotherapy, and in some cases, prophylactic cranial irradiation [13-17].

Page: 1